|
Zila's net working capital on 10/31/99 was $23.3 million, up from
$22.0 million 7/31/99. Its current ratio was a healthy 3.7 to 1,
up from 3.5 to 1 at 7/31/99. Current assets were $31,805,266; total
assets $76,516,840; current liabilities $8,492,489; long-term debt
$9,553,816; & shareholders' equity $51,627,685.
There are three operating groups in Zila: (1) Pharmaceutical --
three entities: Zila Pharmaceuticals [prescription & non-prescription
oral healthcare products]; Zila Biomedical [OraTest(R) oral cancer
detection]; & Zila Biotech [pharmaceutical-grade toluidine blue
-- Zila(R) Tolonium Chloride]. (2) Professional Products -- Zila
Dental Supply, a national dental supplies distributor. (3) Nutriceuticals
-- two entities: Oxycal Laboratories & its Inter-Cal subsidiary
[value-added ingredients including its patented Ester-C(R) branded
products]; & Palmettx(TM) [botanicals for the global nutritional
industry].
Zila appointed ILEX(TM) Oncology Services in November 1999 to
manage clinical & regulatory liaison for OraTest's U.S. regulatory
approval.
Zila was honored by Deloitte & Touche's "Fast 500 Program" as
one of the fastest growing U.S. technology companies, based on five-year
percentage revenue growth (Zila's revenue increase was 1,402%).
Winners, listed in Forbes ASAP magazine 11/29/99, were chosen from
the 22,000 U.S. high tech companies. Call president Joseph Hines
@ 602-266-6700, fax 602-234-2264, or write 5227 N. 7th St., Phoenix,
AZ 85014. www.zila.com [R-7; M-7; L-9]
Disclosure
Conservative Speculator (CS) does not rent, sell, or divulge its
subscription list. We do this to protect our subscribers' privacy.
Rosanne & I are owners of WallStreetCorner.com, Inc. ("WSC"). Per
disclaimers on the site, WSC charges its Charter Participants $2,500
for six months of participation, but there has never been, is not
now, & never will be a charge for editorial coverage in CS, in the
"Larry Oakley's Opinion," Larry Oakley's Weekly Stock Pick," or
"Larry Oakley's Daily Comment" sections of WallStreetCorner, in
my speaking engagements at investment seminars & conferences, or
on radio or TV shows in which I am interviewed. While Rosanne &
I are not owners, officers, or directors of Stockcom Inc. ("SI"),
I occasionally do some consulting for SI.
A company's unique product or service, growth potential, & other
fundamentals that cause me to write about it are similar to characteristics
WSC &/or SI seek. Result: Some companies covered in CS may be invited
by WSC to be participants, or possibly by SI to be customers. I
also cover some companies that became WSC participants or that might
have become SI clients before they were considered candidates for
CS. Being a participant on WSC's site is not a prerequisite to being
covered in CS. I point out to every prospective WSC participant
that coverage in CS is free of charge, & is not a part of their
participation. I am not aware of which companies SI may serve, but
of the 23 Update Briefs, Sneak Previews, & Recommendations in this
issue, DCHT, MAWI, & USVO are participants on WSC.
Any statements in the Recommendations, Update Briefs, Sneak Previews,
or other coverage in this newsletter that are not historical facts
should be considered forward-looking information as that term is
defined in the Private Security Reform Act of 1995. They can often
be identified by such terminology as "predicts," "projects," "believes,"
"estimates," "should," "contemplates," "expects," "anticipates,"
"may," "will," &/or any variation of these &/or similar terms. Such
information & the related company are subject to many risks & uncertainties.
There can be no assurance that actual results, business conditions,
business develop-ments, losses & contingencies, & local & foreign
factors will not differ materially from those suggested in the forward-looking
statements as a result of all sorts of factors (just a few examples:
market conditions, competition, advances in technology, acquisitions,
mergers, potential litigation, personnel changes, market changes,
capital availability). In short, there are absolutely no guarantees
when it comes to future performance. That's one reason why I strongly
recommend that you talk to a senior management person at any company
in which you contemplate taking a position, & form your own opinion
before proceeding with any investment.
|
Important Strategies
These comments apply to every situation mentioned in Conservative
Speculator. Special situation, low-priced, micro-cap, & high-gain-potential
stocks have high risk. Fortunately, not many speculative situations
turn out to be disasters, but some do -- that is a risk you must
accept. Here are three of my most important strategies: 1. Be prudent
-- the total funds allocated to speculative stocks should be limited
to a small percentage of your cash, certainly no more than you could
lose without discomfort. I then suggest no more than 5% of that
small portion be invested in any one stock, to spread your risk.
.... 2. Do not accept my opinion as the reason to invest. Call the
company. Get a feel yourself. If you are not totally comfortable,
pass. I give you an ample number of possibilities. My task is to
expose you to potentially profitable situations. You have the responsibility
of making any investment decision. Do not give up that responsibility.
.... 3. I suggest you apply a moving stop-loss strategy. If the
price goes up, raise your stop-loss guideline point to something
like 20% below the new price. Keep doing that as the price rises.
If the price goes down to your stop-loss point, grit your teeth
& sell. This limits loss, but lets profits increase.
Important Information Regarding CS & Special
Situation Investing
Conservative Speculator ("CS") is published monthly. Contents
copyright by Conservative Speculator. Editor: Lawrence C. Oakley;
Publisher: Rosanne C. Oakley; Researcher: Carol Brown. All rights
reserved. This newsletter, or any part thereof, may not be copied,
duplicated, reprinted, or republished in any form, on or off the
Internet, without the written permission of CS.
Our information is from sources we believe reliable, but we do
not guarantee it; errors are inevitable. It is not all-inclusive.
Do not rely on it as the sole source of data/opinion for making
decisions. Invest in stock only after consulting your investment
advisor, & reviewing financials from the company. Call each company
before investing. CS & its owners are not brokers, dealers, or investment
advisors. Neither the information nor any opinion expressed herein
constitutes an offer or the solicitation of an offer to sell or
buy any security.
We do not endorse the views/opinions of editorial contributors
or our sources of information. Do not assume stocks covered will
be profitable, or will equal past performance. The stocks covered
in CS are highly speculative -- see comments under "Important Strategies."
Art ready-for-camera for reprints of a recommendation in the form
of a two-sided single sheet can be created by Larry Oakley at extra
cost -- call him @ 843-705-5591, fax him at 843-705-5592, or e-mail
him at up415@aol.com. Purchase of art never has been, is not now,
& never will be a prerequisite for editorial coverage. Subscriptions:
$39/year. Access is strictly via Internet delivery at www.WallStreetCorner.com.
To order with VISA, Master, Discover, or AMEX, call 843-705-5591,
fax 843-705-5592, e-mail up415@aol.com, or write Conservative Speculator,
5 Savage Court, Bluffton, SC 29910.
...continued on next page, click here
|